Placing the patient at the heart of Medical Affairs

Written by Gavin Jones, Global Advisor Rare Disease on Tuesday 1st November 2022

This podcast was developed in partnership with the Medical Affairs Professional Society (MAPS).

As patient communities continue to mobilize, they play an increasingly important role in influencing many elements of the drug development journey, and subsequent patient access and support activities. This input ranges from organizing and undertaking natural history studies, recruitment in clinical trials, understanding disease burden, contributing to Health Technology Assessments, and co-creating educational resources that enable shared decision-making and adherence support. This podcast covers the key factors that shape and inform closer collaboration between patient communities and Medical Affairs leaders. Listen now!


Garth Sundem – Director of Communications and Marketing, MAPS


Brittany Wolf Gianares – Director, Patient Centricity Lead, Global Scientific Communications, Pfizer Oncology

Jennifer Ghith – Senior Director, Omnichannel Strategy and Innovations Lead, Global Scientific Communications, Pfizer Oncology

Gavin Jones – Global Advisor, Rare Disease, OPEN Health


For information about OPEN Health’s services and how we could support you, please get in touch.


Visit our careers page to view opportunities at OPEN Health.